Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
asparaginase (elspar) (1 trial)
cytarabine (cytosar-u) (1 trial)
daunorubicin (cerubidine) (1 trial)
naltrexone (revia) (1 trial)
prednisone (meticorten) (1 trial)
urea (1 trial)
vincristine (oncovin) (1 trial)
Leukemia (Phase 3)
Trials (1 total)
Trial APIs (7 total)